The phrase "issued a communication" is correct and usable in written English.
It can be used when referring to the act of formally sending out information or messages, often in a professional or official context.
Example: "The company issued a communication to all employees regarding the new policy changes."
Alternatives: "sent a message" or "distributed a notice."
Last week the European commission issued a communication that considers allowing member states to put in place internal border controls in exceptional circumstances.
In June, the European Commission issued a communication outlining the state of fish stocks, and has proposed fishing limits for 2013.
This year, for the first time, the European Commission issued a communication focused solely on early childhood education and care (European Commission, 2011).
The Charter and Code comes 18 months after the EC issued a communication entitled, "Researchers in the European Research Area: One Profession, Multiple Careers", the first serious indication that the EC was finally addressing the professional needs of the researchers themselves.
Eight years later, in 2000, the European Commission issued a communication on when and how the PP should be applied, intending this to build a common understanding (Commission of the European Communities 2000).
We will issue a Communication [before the summer] next year together with the commissioner for economic affairs Olli Rehn.
Today the EC reiterated the alternative methods available for businesses to enable data flows to continue in the interregnum between data transfer agreements — issuing a Communication which details the various options.
In March 2008, FDA had issued an early communication about investigation of a causal relationship between the drug Singulair and suicides [ 55].
39 The FDA recently issued an Early Communication regarding the possible association between TNF blockers and the development of lymphoma and other malignancies in children and young adults.
21 Tiotropium has a similar mechanism of action to ipratropium, and in 2008, the FDA issued an early communication after a pooled analysis of placebo-controlled clinical trials revealed an excess risk of stroke with tiotropium.
With respect to PAH, the FDA issued a drug safety communication in October 2011 recommending that patients be evaluated for underlying cardiopulmonary conditions before and during dasatinib therapy.
